XVIVO Perfusion AB
Increased Number of Shares and Votes in XVIVO Perfusion AB (publ)
GOTHENBURG, SE / ACCESSWIRE / November 30, 2021 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)
As of today, 30 November 2021, the total number of shares and votes in XVIVO Perfusion AB (publ) is 29,498,666. The number of shares and votes has changed as a result of the directed new issue of 746,269 shares that the company announced on 28 October 2021.
November 30, 2021
XVIVO Perfusion AB (publ)
For further information, please contact:
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2021-11-30 08:00 CET.
SOURCE: XVIVO Perfusion AB
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Trintech, Inc.26.1.2022 17:03:17 CET | Press release
Trintech Is the Only Financial Close Solution Provider with Certified Integrations Across All Microsoft Dynamics 365 Cloud ERP Platforms
Elys Game Technology, Corp.25.1.2022 15:41:51 CET | Press release
Elys Game Technology and Lottomatica S.p.A. Enter into a Binding Term Sheet for Development of a Customized Sportsbook Platform with Focus on North America
XPhyto Therapeutics Corp. 24.1.2022 09:06:46 CET | Press release
XPhyto Provides Update on Integration of 3a-diagnostics GmbH
Cyberlux Corporation21.1.2022 17:32:37 CET | Press release
Cyberlux Corporation Announces Mr. Chris Damvakaris as Chief Revenue Officer to Lead the Revenue Growth Plans and Strategic Partnerships for the Advanced Digital Technology Company
Episode Six18.1.2022 15:04:37 CET | Press release
Third Anniversary of Episode Six and HSBC's Partnership Shows the Power of Banks and Fintechs Working Together
XPhyto Therapeutics Corp. 17.1.2022 09:06:46 CET | Press release
XPhyto Announces Head of Sales, Europe
Loop Industries, Inc.16.1.2022 22:01:39 CET | Press release
Loop Industries Announces Selection of Port-Jérôme, in Normandy, France, as Site for First European Infinite Loop Manufacturing Facility
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom